Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Therapeutic Drug Monitoring|July 27, 2002
Serious neutropenia in ALL patients treated with L-asparaginase may be avoided by therapeutic monitoring of the enzyme activity in the circulationPäivi Ylikangas, Ilkka MononenOrphanet Journal of Rare Diseases|December 2, 2016
Aspartylglycosaminuria: a reviewMaria Arvio, Ilkka MononenGlycobiology|September 3, 2004
Massive accumulation of Man2GlcNAc2-Asn in nonneuronal tissues of glycosylasparaginase-deficient mice and its removal by enzyme replacement therapyEira Kelo, Ulla Dunder, Ilkka MononenJournal of Inherited Metabolic Disease|July 8, 2010
Early initiation of enzyme replacement therapy improves metabolic correction in the brain tissue of aspartylglycosaminuria miceUlla Dunder, Pirjo Valtonen, Eira Kelo, et al.Acta Paediatrica (Oslo, Norway : 1992)|December 9, 2015
Discrepancies between plasma procalcitonin and C-reactive protein levels are common in acute illnessLauri Ivaska, Varpu Elenius, Ilkka Mononen, et al.FEBS Letters|September 26, 2002
Beta-aspartylpeptides as substrates of L-asparaginases from Escherichia coli and Erwinia chrysanthemiEira Kelo, Tiina Noronkoski, Ivanka B Stoineva, et al.The Journal of Allergy and Clinical Immunology|February 6, 2013
Maternal smoking affects lung function and airway inflammation in young children with multiple-trigger wheezeSatu Kalliola, Anna S Pelkonen, L Pekka Malmberg, et al.Clinical Physiology and Functional Imaging|March 27, 2009
Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearanceJuha W Koskenvuo, Erik Engblom, Ilkka M Kantola, et al.Acta Cardiologica|May 13, 2010
Cardiopulmonary involvement in Fabry's diseaseJuha W Koskenvuo, Ilkka M Kantola, Pirjo Nuutila, et al.Basic Research in Cardiology|May 29, 2014
Myocardial blood flow and its transit time, oxygen utilization, and efficiency of highly endurance-trained human heartIlkka Heinonen, Nobuyuki Kudomi, Jukka Kemppainen, et al.Pageof 1